NCT07718737 — NSCLC (Advanced Non-small Cell Lung Cancer) trial site landscape

Public-registry site landscape for NCT07718737, a NSCLC (Advanced Non-small Cell Lung Cancer) study sponsored by Multitude Therapeutics Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07718737 (registry record)
Sponsor	Multitude Therapeutics Inc.
Condition(s)	NSCLC (Advanced Non-small Cell Lung Cancer)
Phase	PHASE2 / PHASE3
Listed sites	5
Site countries	Australia

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07718737 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.